Nventric Overview
- Year Founded
-
2019
- Status
-
IPO Registration
- Employees
-
29
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
23
Nventric General Information
Description
Developer of a medical device designed to remove blood clots that cause ischemic stroke. The company generates a medical device that inserts a stent retriever into the artery in the leg to remove the blood clot that causes arterial occlusion, enabling doctors to access devices to treat ischemic stroke and enhance their treatment procedure.
Contact Information
Website
www.nventric.comCorporate Office
- 150 North Santa Anita Avenue
- Suite 400
- Arcadia, CA 91006
- United States
Corporate Office
- 150 North Santa Anita Avenue
- Suite 400
- Arcadia, CA 91006
- United States
Nventric Timeline
Nventric Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. IPO | 10-Jun-2026 | Announced | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 10-Jun-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 06-Feb-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Sep-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 09-Jul-2019 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-May-2019 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nventric Patents
Nventric Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021020767-A1 | Thrombus removal device | Inactive | 29-Jul-2019 | ||
| WO-2021020765-A1 | Thrombus removing device and thrombus removing method using same | Inactive | 29-Jul-2019 | ||
| WO-2021020766-A1 | Thrombus removing device and thrombus removing method using same | Inactive | 29-Jul-2019 | ||
| WO-2020162724-A1 | Occlusive thrombus removal device and occlusive thrombus removal method | Inactive | 08-Feb-2019 |
Nventric Signals
Nventric Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AJU IB Investment | Venture Capital | Minority | ||
| Flexus Partners | Venture Capital | Minority | ||
| HB Investment | Venture Capital | Minority | ||
| LB Investment | Venture Capital | Minority | ||
| Loftyrock Investment | Venture Capital | Minority |
Nventric FAQs
-
When was Nventric founded?
Nventric was founded in 2019.
-
Where is Nventric headquartered?
Nventric is headquartered in Arcadia, CA.
-
What is the size of Nventric?
Nventric has 29 total employees.
-
What industry is Nventric in?
Nventric’s primary industry is Surgical Devices.
-
Is Nventric a private or public company?
Nventric is a Private company.
-
What is Nventric’s current revenue?
The current revenue for Nventric is .
-
How much funding has Nventric raised over time?
Nventric has raised $22.8M.
-
Who are Nventric’s investors?
AJU IB Investment, Flexus Partners, HB Investment, LB Investment, and Loftyrock Investment are 5 of 23 investors who have invested in Nventric.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process